Vaccine Safety: An examination of the value and necessity of Phase III trials Fulltext Access 8 Pages 2011
Vaccination rates of healthcare workers vary according to their occupational group Fulltext Access 5 Pages 2011
Production and purification of recombinant fragment of pneumococcal surface protein A (PspA) in Escherichia coli Fulltext Access 9 Pages 2011
Mucosal immunization with IpaD adjuvanted by IC31® elicits protection in a murine model of shigellosis Fulltext Access 6 Pages 2011
A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model Fulltext Access 8 Pages 2011
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) Fulltext Access 9 Pages 2011
Possible Herd Immunity in the Elderly Following the Vaccination of School Children with Live, Attenuated Trivalent Influenza Vaccine: A Person-Level Analysis Fulltext Access 12 Pages 2011
Immunogenicity of Unadjuvanted and AF03-Adjuvanted A/H1N1/California/07/2009 Influenza Vaccines in Naïve and Influenza-Primed Mice Fulltext Access 7 Pages 2011
Preclinical evaluation of influenza vaccines based on replication-deficient poxvirus vector MVA Fulltext Access 6 Pages 2011
Protective antibody titer for patients vaccinated against tickborne encephalitis virus Fulltext Access 8 Pages 2011
Perspective of using the recombinant DNA-technology to control the spread of the African swine fever Fulltext Access 8 Pages 2011
A live vaccine is safe and efficient to protect poultry against histomonosis Fulltext Access 4 Pages 2011
Novel Formulation Concept for Particulate Uptake of Vaccines via the Nasal Associated Lymphoid Tissue Fulltext Access 7 Pages 2011